[1]
“FREQUENCY OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) IN PATIENTS WITH METABOLIC SYNDROME”, RMSR, vol. 3, no. 3, pp. 812–818, Mar. 2025, Accessed: Aug. 06, 2025. [Online]. Available: https://medscireview.net/index.php/Journal/article/view/821